Literature DB >> 17547477

Imidapril: will fewer adverse events translate into better long-term outcomes?

Tom Richart1, Jan A Staessen, Willem H Birkenhäger.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 17547477     DOI： 10.2165/00003495-200767090-00009

Source DB:  PubMed          Journal:  Drugs        ISSN： 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  29 in total

1.  Vasopeptidase inhibition and angio-oedema.

Authors:  F H Messerli; J Nussberger
Journal:  Lancet       Date:  2000-08-19       Impact factor: 79.321

2.  Aldosterone escape during angiotensin-converting enzyme inhibitor therapy in essential hypertensive patients with left ventricular hypertrophy.

Authors:  A Sato; T Saruta
Journal:  J Int Med Res       Date:  2001 Jan-Feb       Impact factor: 1.671

3.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

Authors:  S Yusuf; P Sleight; J Pogue; J Bosch; R Davies; G Dagenais
Journal:  N Engl J Med       Date:  2000-01-20       Impact factor: 91.245

4.  Angiotensin-converting enzyme inhibitors can potentiate ozone-induced airway hyperresponsiveness.

Authors:  S Matsubara; H Kikkawa; O Kaminuma; K Ikezawa
Journal:  Eur J Pharmacol       Date:  1997-10-22       Impact factor: 4.432

5.  Pharmacokinetic and pharmacodynamic interaction trial after repeated oral doses of imidapril and digoxin in healthy volunteers.

Authors:  S Harder; P A Thürmann
Journal:  Br J Clin Pharmacol       Date:  1997-05       Impact factor: 4.335

6.  Asphyxia due to angiotensin converting enzyme (ACE) inhibitor mediated angioedema of the tongue during the treatment of hypertensive heart disease.

Authors:  D E Dean; D L Schultz; R H Powers
Journal:  J Forensic Sci       Date:  2001-09       Impact factor: 1.832

Review 7.  The clinical use of angiotensin-converting enzyme inhibitors.

Authors:  Joseph Wong; Rajiv A Patel; Peter R Kowey
Journal:  Prog Cardiovasc Dis       Date:  2004 Sep-Oct       Impact factor: 8.194

8.  Clinical events in high-risk hypertensive patients randomly assigned to calcium channel blocker versus angiotensin-converting enzyme inhibitor in the antihypertensive and lipid-lowering treatment to prevent heart attack trial.

Authors:  Frans H H Leenen; Chuke E Nwachuku; Henry R Black; William C Cushman; Barry R Davis; Lara M Simpson; Michael H Alderman; Steven A Atlas; Jan N Basile; Aloysius B Cuyjet; Richard Dart; James V Felicetta; Richard H Grimm; L Julian Haywood; Syed Z A Jafri; Michael A Proschan; Udho Thadani; Paul K Whelton; Jackson T Wright
Journal:  Hypertension       Date:  2006-07-24       Impact factor: 10.190

Review 9.  Imidapril: a review of its use in essential hypertension, Type 1 diabetic nephropathy and chronic heart failure.

Authors:  Dean M Robinson; Monique P Curran; Katherine A Lyseng-Williamson
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 10.  Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis.

Authors:  Juan P Casas; Weiliang Chua; Stavros Loukogeorgakis; Patrick Vallance; Liam Smeeth; Aroon D Hingorani; Raymond J MacAllister
Journal:  Lancet       Date:  2005-12-10       Impact factor: 79.321
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.